BLOOMINGTON, Ind., Jan. 19, 2017 -- Megaputer Intelligence announced today that it will host a live webinar series titled “Text Analytics for Pharma” beginning on January 31, 2017. A set of nine free webinars comprising this series will highlight how advanced text analytics helps address typical challenges encountered in the pharmaceutical and life sciences domains:
- Detection of potential adverse events
- Extraction of facts from academic publications
- Analysis of call center transcripts
- Survey data analysis
- Medical device repair notes analysis
- Competitive intelligence
- Social media analysis
Presenters will discuss the underworkings and practical implementations of advanced computational linguistics techniques, as well as the foundations of systems for the analysis of BIG DATA. Topics will be presented by data and text analysis specialists with relevant domain expertise. The webinar series is scheduled to run from January to April 2017.
The webinars will provide business practitioners with a clear understanding of frequently encountered individual tasks and outline the technology, implementation path, results, and benefits of the analytical solutions developed at industry-leading companies for addressing these tasks.
For more information and to register for the webinars, visit www.polyanalyst.com/webinars. Advance registration is encouraged, as availability is limited for each webinar.
About Megaputer Intelligence
Megaputer Intelligence (www.megaputer.com) is a leading developer of data and text mining software and custom analytical solutions for various application domains. Megaputer analytical tools enable over 500 customers worldwide to make informed data-driven decisions.
Megaputer is a registered trademark of Megaputer Intelligence Inc. in the United States and/or other countries. The names of other companies and products mentioned herein may be the trademarks of their respective owners.
For more information: Brian Howard Megaputer Intelligence, Inc. (812) 330-0110 ext. 215 [email protected]


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



